Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia.
about
Immune Cells in Cancer Therapy and Drug DeliveryTargeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidenceT-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effectCUZD1 and anti-CUZD1 antibodies as markers of cancer and inflammatory bowel diseasesMinimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical ApplicationsExpression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.Minimal Residual Disease in Acute Myeloid Leukemia: Still a Work in Progress?Minimal residual disease in acute myeloid leukaemiaInterleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.Screening of multiple myeloma by polyclonal rabbit anti-human plasmacytoma cell immunoglobulin.Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy.Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantationIdentification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies.Inducible T-cell receptor expression in precursor T cells for leukemia control.Generating Peripheral Blood Derived Lymphocytes Reacting Against Autologous Primary AML Blasts.Programmed death-1 checkpoint blockade in acute myeloid leukemia.Can immunotherapy specifically target acute myeloid leukemic stem cells?Twenty years of experience on stem cell transplantation in iran.Adoptive Immunotherapy For Leukemia With Ex vivo Expanded T Cells.Dendritic cell-based immunotherapy for myeloid leukemias.Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.Design of an Optimized Wilms' Tumor 1 (WT1) mRNA Construct for Enhanced WT1 Expression and Improved Immunogenicity In Vitro and In VivoAnti-leukemia T cells in AML: TNF-α⁺ CD8⁺ T cells may escape detection and possibly reflect a stage of functional impairment.Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients.Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies.Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia.Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation.Current strategies in immunotherapy for acute myeloid leukemia.Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.Hematopoietic stem cell transplantation and immunotherapy for pediatric acute myeloid leukemia: an open challenge.Regulation of hematopoietic and leukemic stem cells by the immune system.ZRF1 controls the retinoic acid pathway and regulates leukemogenic potential in acute myeloid leukemia.Update on antigen-specific immunotherapy of acute myeloid leukemia.Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia.Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?Challenges in vaccine therapy in hematological malignancies and strategies to overcome them.Progress of dendritic cell-based cancer vaccines for patients with hematological malignancies.Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury.Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.
P2860
Q26747061-460FCE2A-62FB-4B08-BD8E-0879DF680E70Q26770388-FC9CDD33-4D1F-4CAF-AB61-C0292930E8D8Q26826830-A2F431F6-4816-49D5-A588-55D55CF5BBBDQ26999045-C6470F30-2AA0-4BAE-AE3E-1088D94443A1Q28073464-4D9C1084-787B-4467-AB8C-195E842C3633Q33657377-D9C905CC-DB25-42B6-9DD2-20BEA62BF7F3Q33832709-5C84ADE8-D342-4D22-86C9-DD65EADB4A6BQ34179265-D6542245-2E79-4F10-9CDB-22EF6922679AQ34532389-44BB65E0-BDB6-4D30-93D5-B1EFCC3E4827Q34656161-FC53E997-CD56-4AEE-B56F-8095D03728B7Q34980976-8D82B3AF-D920-4A05-986E-EDBD0416A497Q35588845-01F50864-95AE-4C5F-B261-C8C58FEB72ECQ35897592-75D6EE41-17D8-481E-8039-FA27B8BEA55BQ36166038-068D9B6D-7145-4796-8156-28876A2B8624Q36558219-D97E443A-7593-4750-A865-3BF78D119A8EQ36652124-876DF5DC-D5E2-424C-90A9-B480DDC55B08Q36694901-A90DEB65-A749-4A7C-AE58-37D22A3B8FDAQ36839332-81F57387-5AB0-4991-B59F-A8BE8DA2E0B0Q37242561-85AF206F-65F6-4220-BBA0-B66BF4357CE0Q37420778-C3A743CD-E9DD-48CE-81B2-BB58814BAD79Q37429706-904B42AC-E43E-4E51-9008-452EC799B4AAQ37467831-0C09B112-3A8E-492D-B332-951A609F6828Q37514720-4B97CCE6-BE54-46B3-BF9D-4321D68EA40DQ37545824-F8CE7F73-848B-4564-B1B9-C81A088703E7Q37587362-B9DE2D49-5E90-4A19-AE4D-14DF9328154FQ37641560-A49A8ADF-318F-4D1E-847D-1674A01E39EEQ37676299-D9C4EA27-32DC-4A7E-896F-AA3F5C940818Q38068967-1ECE8789-4D6F-4235-B84B-F54800850C1DQ38115438-1DDA2335-FEEC-4E51-954B-0A2177A1D7DBQ38195065-5946E68C-E40D-4CB3-9CA9-522140493111Q38225994-D909264C-84D1-4E44-BF43-2A6AC5716390Q38310769-97D6E5F3-9689-44AE-9CA7-BB900314B6C3Q38432103-7D594611-0DC2-4D9B-B5C5-8121F3089CD0Q38485334-EC0D0F3B-56C9-4D72-9020-57E2E8B5C617Q38664735-DB9746E5-C275-4182-8E81-D89ADC9A3918Q38700209-6F83CB7C-DEBF-452A-B946-CD828A37F58FQ38843235-49D4A6E6-852A-4810-88B8-2BE4B7859C7DQ38847756-8F56EC83-26DC-489D-90D0-2C492C04A59BQ39037091-10AFCE88-A18E-4C75-98E7-F420F5320CCCQ39243052-B74B5266-5BFF-4265-9954-0F09A0DF9C55
P2860
Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Leukemia-associated antigens a ...... apy of acute myeloid leukemia.
@en
type
label
Leukemia-associated antigens a ...... apy of acute myeloid leukemia.
@en
prefLabel
Leukemia-associated antigens a ...... apy of acute myeloid leukemia.
@en
P2860
P356
P1433
P1476
Leukemia-associated antigens a ...... rapy of acute myeloid leukemia
@en
P2093
S Anguille
V F Van Tendeloo
P2860
P2888
P304
P356
10.1038/LEU.2012.145
P577
2012-06-01T00:00:00Z
P5875
P6179
1028497155